0001104659-21-046191.txt : 20210402 0001104659-21-046191.hdr.sgml : 20210402 20210402180944 ACCESSION NUMBER: 0001104659-21-046191 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210331 FILED AS OF DATE: 20210402 DATE AS OF CHANGE: 20210402 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Dolan Daniel CENTRAL INDEX KEY: 0001826818 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37558 FILM NUMBER: 21803257 MAIL ADDRESS: STREET 1: C/O NABRIVA THERAPEUTICS PLC STREET 2: 1000 CONTINENTAL DRIVE, SUITE 600 CITY: KING OF PRUSSIA STATE: PA ZIP: 19406 FORMER NAME: FORMER CONFORMED NAME: Dolan Dan DATE OF NAME CHANGE: 20200930 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Nabriva Therapeutics plc CENTRAL INDEX KEY: 0001641640 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L2 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 56 FITZWILLIAM SQUARE CITY: DUBLIN STATE: L2 ZIP: 2 BUSINESS PHONE: (610) 816-6640 MAIL ADDRESS: STREET 1: 1000 CONTINENTAL DRIVE STREET 2: SUITE 600 CITY: KING OF PRUSSIA STATE: PA ZIP: 19406 FORMER COMPANY: FORMER CONFORMED NAME: Nabriva Therapeutics AG DATE OF NAME CHANGE: 20150507 4 1 tm2112032-1_4seq1.xml OWNERSHIP DOCUMENT X0306 4 2021-03-31 0 0001641640 Nabriva Therapeutics plc NBRV 0001826818 Dolan Daniel 1000 CONTINENTAL DRIVE SUITE 600 KING OF PRUSSIA PA 19406 0 1 0 0 Chief Financial Officer Stock Option 1.66 2021-03-31 4 A 0 100000 0 A 2031-03-30 Ordinary Shares 100000 100000 D The option was granted on March 31, 2021. The option will vest over a four-year period. Twenty-five percent (25%) of the option will vest on the one (1)-year anniversary of the date of grant, and the remaining seventy-five percent (75%) of the option will vest on an annual pro-rata basis over the remaining vesting period. /s/ Robert Crotty, by power of attorney 2021-04-02